Meet Ultima at EACR: Liquid Biopsies, September 22-24
Our team is looking forward to discussing how our whole-genome sequencing method, ppmSeq™ for minimal residual disease (MRD) detection, is redefining what’s possible in cancer genomics. From accelerating large‑scale studies to enabling earlier, more precise detection of recurrence, Ultima is delivering the power, speed, and resolution researchers need to unlock the next breakthroughs in cancer science.
Learn more about EACR: Liquid BiopsiesJoin our session: Industry Spotlight
Detection of MRD in localized colon cancer with Ultima ppmSeq sequencing technology
- Time: 8:45 AM - 9:00 AM CEST
- Speaker:
-
Alex Watkins Staff Field Applications Scientist Ultima Genomics Talk title: Using Ultima Genomics technology to detect minimal residual disease
-
- Location: Plenary Session
Meet the team
Meet our team at Table #17
